794
Views
4
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Stevens-Johnson syndrome following concurrent phenytoin and holocranial radiotherapy

, , &
Pages 259-260 | Received 09 Jul 2009, Accepted 07 Aug 2009, Published online: 05 Nov 2009

References

  • Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: A case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet. 1999; 353:2190–4.
  • Allergic Leong KP, Chng HH. Reactions to phenytoin in a general hospital in Singapore. Asian Pac J Allergy Immunol. 1996; 14:65–8.
  • Ahmed I, Reichenberg J, Lucas A, Shehan JM. Erythema multiforme associated with phenytoin and cranial radiation therapy: A report of three patients and review of the literature. Int J Dermatol. 2004; 43:67–73.
  • Ruggiero A, Buonuomo PS, Maurizi P, Cefalo MG, Corsello M, Riccardi R. Stevens-Johnson syndrome in children receiving phenobarbital therapy and cranial radiotherapy. J Neurooncol. 2007; 85:213–5.
  • Hoang-Xuan K, Delattre JY, Poisson M. Stevens-Johnson syndrome in a patient receiving cranial irradiation and carbamazepine. Neurology. 1990; 40:1144–5.
  • Metro G, Pino S, Pellegrini D, Sacerdoti G, Fabi A. Brain radiotherapy during treatment with anticonvulsant therapy as a trigger for toxic epidermal necrolysis. Anticancer Res. 2007; 27:1167–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.